Singaporean firm Mirxes enters Hong Kong to tap into growing multi-cancer early-stage screening market in Greater Bay Area
Mirxes, a spin-off of Singapore ’s Agency for Science, Technology and Research, expects China’s multi-cancer early-stage screening market to expandThe start-up’s move to Hong Kong followed its application in July for an IPO in the city’s stock exchange
Hong Kong Zhou Lihan Prenetics Group South China Morning Post Horizon Health International Agency For Research On Cancer
Source: thestar.com.my